Birth Control Pills Recalled Over Potential Pregnancy Risk

Share this content:
Birth Control Pills Recalled Over Potential Pregnancy Risk
Birth Control Pills Recalled Over Potential Pregnancy Risk

WEDNESDAY, May 30, 2018 (HealthDay News) -- Almost 170,000 birth control pill packs are being recalled over a manufacturing error that could lead to unplanned pregnancy, maker Allergan says.

Taytulla physician sample packs include active capsules and inactive placebos that are designed to be taken in a certain order. The recalled packs may have been packaged out of order, so that a person who expected to take an active capsule may actually take a placebo, CBS News reported.

Allergan said the error was isolated to a single pack, but the entire lot was recalled as a precaution. The packs are marked with lot number 5620706 and an expiration date of May 2019, CBS News said. The network reported Allergan would notify users by letter.

"If patients have concerns regarding the possibility of an unintended pregnancy, they should consult their physician," Allergan said in a recall statement posted by the U.S. Food and Drug Administration.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Deep Learning-Enhanced Device Detects Diabetic Retinopathy

Deep Learning-Enhanced Device Detects Diabetic Retinopathy

Device sensitivity/specificity 100/97.8 percent for vision-threatening diabetic retinopathy

Altered Gut Microbiome Seen in Patients With Active Lupus

Altered Gut Microbiome Seen in Patients With Active ...

Patients with lupus had fivefold greater representation of Ruminococcus gnavus

Combo Regimens Effective for Tx of Metastatic Renal Cell Cancer

Combo Regimens Effective for Tx of Metastatic Renal ...

Two large trials show benefits for pembrolizumab-axitinib and avelumab-axitinib versus sunitinib

is free, fast, and customized just for you!




Already a member?

Sign In Now »